Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis

This study has been completed.
Information provided by (Responsible Party):
Motus Therapeutics, Inc. Identifier:
First received: July 8, 2011
Last updated: September 21, 2016
Last verified: September 2016